![John McDonald](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
John McDonald
Directeur/Membre du Conseil chez
GERON CORPORATION
Fortune : - $ au 30/06/2026
Profil
Mr. John F.
McDonald is an Independent Director at Geron Corp., an Independent Director at Nouscom AG, a VP, Global Head-Business Development, M&A at Novo Nordisk A/S and an Operating Partner at Forbion Capital Partners Management Holding.
He is on the Board of Directors at Geron Corp., Nouscom AG and Nouscom Srl.
Mr. McDonald was previously employed as a Vice President-Business Development by Biogen, Inc., a Co-Founder by Solasia Pharma KK, a Managing Director by MPM BioImpact LLC, a Principal by Genzyme Corp., and a Vice President-Business Development by Millennium Pharmaceuticals, Inc. He also served on the board at CalciMedica Subsidiary, Inc. He received his undergraduate degree from Haas School of Business, a graduate degree from the University of California, Hastings and an MBA from Haas School of Business.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
GERON CORPORATION -.--% | 20/05/2026 | 0 ( -.--% ) | - $ | 30/06/2026 |
Postes actifs de John McDonald
| Sociétés | Poste | Début |
|---|---|---|
| GERON CORPORATION | Directeur/Membre du Conseil | 07/09/2022 |
| NOVO NORDISK A/S | Corporate Officer/Principal | 01/10/2018 |
Nouscom AG
 Nouscom AG Pharmaceuticals: MajorHealth Technology Operates as an oncology company that develops immunotherapies | Directeur/Membre du Conseil | 05/11/2018 |
Nouscom Srl
 Nouscom Srl Miscellaneous Commercial ServicesCommercial Services Operates as a next-generation immunotherapy company that develops engineered viral vectored vaccines for treatment of cancer | Directeur/Membre du Conseil | - |
Anciens postes connus de John McDonald
| Sociétés | Poste | Fin |
|---|---|---|
| BIOGEN INC. | Corporate Officer/Principal | 01/09/2018 |
CalciMedica Subsidiary, Inc.
 CalciMedica Subsidiary, Inc. BiotechnologyHealth Technology Engages in drug development | Directeur/Membre du Conseil | - |
Genzyme Corp.
 Genzyme Corp. Pharmaceuticals: MajorHealth Technology Develops and manufactures therapies for rare diseases, multiple sclerosis, immunology & oncology | Corporate Officer/Principal | - |
| SOLASIA PHARMA K.K. | Fondateur | - |
Millennium Pharmaceuticals, Inc.
 Millennium Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures medicines for oncology treatment | Corporate Officer/Principal | - |
Formation de John McDonald
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
67
Relations au 1er degré
12
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 12 |
|---|---|
Millennium Pharmaceuticals, Inc.
Millennium Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures medicines for oncology treatment | Health Technology |
Biogen, Inc.
 Biogen, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and markets therapies for neurological and neurodegenerative diseases | Health Technology |
Geron Corp.
 Geron Corp. BiotechnologyHealth Technology Discovers and develops therapeutic products for cancer | Health Technology |
Novo Nordisk A/S
 Novo Nordisk A/S Pharmaceuticals: MajorHealth Technology Manufactures and markets pharmaceutical products for diabetes care | Health Technology |
Genzyme Corp.
Genzyme Corp. Pharmaceuticals: MajorHealth Technology Develops and manufactures therapies for rare diseases, multiple sclerosis, immunology & oncology | Health Technology |
CalciMedica Subsidiary, Inc.
CalciMedica Subsidiary, Inc. BiotechnologyHealth Technology Engages in drug development | Health Technology |
MPM BioImpact LLC
 MPM BioImpact LLC Investment ManagersFinance MPM Capital invests in both public and private companies located in the United States. The firm targets companies operating in the fields of biotechnology, healthcare and life science sectors. It participates in early stage capital transactions. | Finance |
University of California, Hastings
 University of California, Hastings Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Solasia Pharma KK
 Solasia Pharma KK Pharmaceuticals: MajorHealth Technology Engages in the development, sale, import and export of pharmaceutical products and medical devices | Health Technology |
Haas School of Business
 Haas School of Business Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Nouscom AG
Nouscom AG Pharmaceuticals: MajorHealth Technology Operates as an oncology company that develops immunotherapies | Health Technology |
Nouscom Srl
Nouscom Srl Miscellaneous Commercial ServicesCommercial Services Operates as a next-generation immunotherapy company that develops engineered viral vectored vaccines for treatment of cancer | Commercial Services |
